Aciflux (20+150) is a Fixed-Dose Combination (FDC) Drug Brand being manufactured and marketed by S.H. Pharmaceuticals Ltd.. This medicine is combination of more than one active ingredient or substance within a single pharmaceutical form type. The main active ingredients or salts in this drug are Rabeprazole Sodium, Itopride. This drug comes in the form of Capsule. The general packing available for this medicine consists of 10 Capsule and is priced at Rs 103 (arround $1.442 US Dollar)
Generic (Salt) Combination :
(Rabeprazole Sodium+ Itopride)
Pharma Company :
S.H. Pharmaceuticals Ltd.
Brand Label :
Aciflux (20+150)
Preparation Type :
Capsule
Single Dose :
1 Capsule
Composition (Fixed-Dose Combination) :
Itopride-150 mg
Rabeprazole Sodium-20 mg
Pack Size/Qty/Vol :
10 Capsule
Price Unit :
Rs 10.3 INR (arround $0.1442 US Dollar)
Price Pack :
Rs 103 INR (arround $1.442 US Dollar)
Drug details for Aciflux (20+150)
Usage: Why is this medication prescribed?
The main active ingredients or salts in Aciflux (20+150) are :
Itopride-150 mg
Rabeprazole Sodium-20 mg
Rabeprazole Sodium Indication (Prescribed for or used as): Benign gastric ulcer
For more details on Rabeprazole Sodium, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Rabeprazole Sodium..
Itopride Indication (Prescribed for or used as): Feeling of gastric fullness, epigastric pain, anorexia, heartburn, regurgitation, bloating nausea and vomiting.
For more details on Itopride, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Itopride..
Aciflux (20+150) Drug Brands Substitutes with similar Fixed-Dose Combination (FDC) :
There are 2 Fixed-Dose Combination (FDC) Drug Brands listed here as Substitutes for Aciflux (20+150), which have same Fixed-Dose Combination of active substances or ingredients (i.e. Itopride-150 mg Rabeprazole Sodium-20 mg). Please note that one can request a doctor or pharmacist to substitute a FDC Brand Version of the prescribed FDC drug brand, if any. Fixed-Dose Combination Drugs are being increasingly used due to the benefit of the combined effects of active ingredients given together. However, it is necessary to investigate the possible benefits in the clinical situation against possible disadvantages for each fixed combination drug and for each dose of the fixed combination drug. Potential advantages of fixed combination drugs may also include the counteracting by one ingredient of an adverse reaction produced by another one, and simplification of therapy, leading to improved compliance.